导航风险超越标签:解封全球营养补充剂安全性
Floris C Wardenaar1, Stephen F Burns2, Marcus Campos3
1Athleat Field Lab, College of Health Solutions, Arizona State University, Phoenix, AZ, USA.
International journal of sport nutrition and exercise metabolism
|December 30, 2025
概括
运动员广泛使用营养补充剂,但不一致的法规和有限的安全监督可能会导致兴奋剂违规. 第三方测试 (TPT) 有助于减轻风险,尽管全球访问和运动员对TPT认证的认识有很大差异.
科学领域:
- 运动科学 运动科学 运动科学
- 营养生物化学 营养生物化学
- 监管事务 监管事务
背景情况:
- 营养补充剂的使用在寻求提高表现和改善健康的运动员中很普遍.
- 不一致的全球监管框架和安全监督构成意外兴奋剂违规的风险.
- 第三方测试 (TPT) 是缓解这些风险的关键策略.
研究的目的:
- 提供补充剂使用,法规和安全措施的全球概述.
- 评估第三方测试在降低风险方面的作用和局限性.
- 确定低风险补充剂使用的障碍,并提出建议.
主要方法:
- 综合了来自全球六个地区的同行评审研究,政府来源和区域专家的数据.
- 分析报告的补充剂使用模式,包括常见的和高风险的产品.
- 评估第三方测试 (TPT) 程序的可用性,意识和遵守情况.
主要成果:
- 在全球的运动员中,补充剂的使用幅度很大 (7%100%),常见的产品包括蛋白质粉,维生素,肌酸,咖啡因和运动饮料.
- 高风险的补充剂,可能导致反兴奋剂规则违规,在所有地区都存在.
- 第三方测试 (TPT) 计划集中在全球西北部,运动员的意识和坚持不一致.
结论:
- 在运动员中,关于补充剂安全性和认证存在重大误解.
- 有限的TPT可用性,成本,标签差异和文化因素阻碍了低风险补充剂的使用.
- 建议包括加强教育,改善全球获得TPT认证补充剂的机会,以及协调安全标准.
相关概念视频
01:30Vitamins
2.2K
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.2K
01:25Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:07Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
162
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
162
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
152
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
152